Durable responses after ibritumomab tiuxetan radioimmunotherapy for CD20+ B-cell lymphoma: long-term follow-up of a phase 1/2 study. (Q47963607)
Jump to navigation
Jump to search
scientific article published on 11 March 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Durable responses after ibritumomab tiuxetan radioimmunotherapy for CD20+ B-cell lymphoma: long-term follow-up of a phase 1/2 study. |
scientific article published on 11 March 2004 |
Statements
1 reference
Durable responses after ibritumomab tiuxetan radioimmunotherapy for CD20+ B-cell lymphoma: long-term follow-up of a phase 1/2 study. (English)
1 reference
1 reference
Arturo Molina
1 reference
Thomas Witzig
1 reference
Christos Emmanouilides
1 reference
Andrew Raubtischek
1 reference
Mohamed Darif
1 reference
Russell J Schilder
1 reference
Greg Wiseman
1 reference
Christine A White
1 reference
11 March 2004
1 reference
1 reference
103
1 reference
12
1 reference
4429-4431
1 reference
Identifiers
1 reference
1 reference